22 marzo 2016 anni - FDA requires a new boxed warning about the serious risks of misuse and abuse, which can lead to addiction, overdose and death. The FDA also requires several additional safety labeling changes across all prescription opioid products to include additional information on the risk of these medications.
Aggiunto al nastro di tempo:
Data:
22 marzo 2016 anni
Adesso
~ 8 years and 2 months ago
